Analysis of global biochips industry, 2012 2018 - market research study analysis

1. www.axisresearchmind.com | Copyright © 2014 | All Rights Reserved
ANALYSIS OF GLOBAL BIOCHIPS
INDUSTRY, 2012-2018
GLOBAL TRENDS, ESTIMATES AND FORECASTS
PRICE: US$4450
NO. OF PAGES: 483
TABLES/CHARTS: 182
REPORT CODE: ARMMR114N.1
PUBLICATION: JUNE 2014

2. www.axisresearchmind.com | Copyright © 2014 | All Rights Reserved
For more information on this report publication, please reach us at:
sales@axisresearchmind.com 2
ANALYSIS OF GLOBAL BIOCHIPS INDUSTRY, 2012-2018
GLOBAL TRENDS, ESTIMATES AND FORECASTS
BIOCHIPS - SEGMENTATION
BY SEGMENT BY APPLICATION
Microarrays
o By Type
 DNA Biochips
 Lab-on-Chips
 Protein Biochips
 Tissue Microarray
 Others
Cell-on Chips
Organ-on-Chips
Human-on-Chips
o By Technology
 Gene Expression
 SNP Identification
 High Throughput Screening
 Proteomics
Biochip Related Products
o Instruments
o Reagents and Consumables
o Software
Services
Drug Discovery and Development
Diagnostics and Treatment
Research
Forensic
Other (Agriculture, Environmental
Sensors, Food Inspection)
REPORT FOCUS
The ‘Analysis of Global Biochips Industry, 2012-2018’ reviews the latest trends in
biochips sector with a perceptive to disclose the near-future growth prospects in. An
in-depth analysis across the geographic regions provides strategic business intelligence
for life science and as well as healthcare sector investments. The study offers
profitable investment strategies for R&D organizations, pharmaceutical
manufacturers, biotechnology companies, laboratories, Contract Research
Organizations (CROs) and many more in preferred locations.
“Learn High Potential Market Dynamics
for Strategic Business Planning”

3. www.axisresearchmind.com | Copyright © 2014 | All Rights Reserved
For more information on this report publication, please reach us at:
sales@axisresearchmind.com 3
ANALYSIS OF GLOBAL BIOCHIPS INDUSTRY, 2012-2018
GLOBAL TRENDS, ESTIMATES AND FORECASTS
The report focuses on the current market trends, estimates and forecasts for the
period 2012-2018. More than 640 in biochips market and 56 leading market players
that project improved market activities in the near future are profiled. The report
consists of 182 data charts describing the market shares, sales forecasts and growth
prospects. Moreover, key strategic activities in the market including
mergers/acquisitions, collaborations/partnerships, product launches/developments
are discussed which gives a deep insight into the growth perspectives of the market.
Estimates are based on online surveys using customized questionnaires by our research
team. Besides information from government databases, company websites, press
releases and published research reports are also used for estimates. Estimates have
incorporated recessionary impact on the industry. The analysis is based on desk
research and interviews with biochips researchers and law/ethics specialists, as well
as on data collected through the survey, and discussions with experts.
KEY COMPANIES PROFILED
BD Biosciences, Promega Corporation, Roche Nimblegen, INC., Perkinelmer Life
Sciences, Affymetrix, INC., Agilent Technologies, Life Technologies Corporation,
Qiagen N.V., Fluidigm Corporation, GE Healthcare, Amgen, Siemens Medical Solutions,
Affibody AB, Hipep Laboratories, Ocimum Biosolutions Ltd., Bioneer Corp. DR. Chip
Biotechnology Inc. & many more….
Analysis of Global Biochips Industry, 2012-2018
Global biochips market is forecasted to reach US$11.4 billion by 2018 with a CAGR of
18.6% during 2012-2018; the massive CAGR is primarily supported by Asia-Pacific
followed by the European Union. Among the major industry segments, biochips
instruments are expected to exert the
highest support to the industry with a
CAGR of 20% globally. Microarrays
segment accounts for nearly 70% of the industry value while services indicate lesser
than 15% of the market value. North America is expected to maintain the highest
market share for the biochips industry by 2018; Asian economies are expected to post
a large CAGR of 19 percent during 2012-2018. Higher growth rate favors improved
industry investments in Asia-Pacific region in comparison with North America and
Europe, going ahead.
“Getting the Most from Our Research Analysis”

4. www.axisresearchmind.com | Copyright © 2014 | All Rights Reserved
For more information on this report publication, please reach us at:
sales@axisresearchmind.com 4
ANALYSIS OF GLOBAL BIOCHIPS INDUSTRY, 2012-2018
GLOBAL TRENDS, ESTIMATES AND FORECASTS
GEOGRAPHIC COVERAGE
Incorporating the recession impacts on the industry, the market growth rate in the
major economies such as the U.S., Japan and China along with the other emerging
countries are estimated individually for the upcoming years. The market growth rate
in the major economies such as the U.S., Japan, China etc. are estimated individually
for the upcoming years.
The region-wise distribution of the market consists of North America, Asia-Pacific,
Europe and Rest of World with 13 countries, analyzed individually as follows:
NORTH AMERICA USA & CANADA
ASIA-PACIFIC
JAPAN, CHINA, INDIA, SOUTH KOREA, AUSTRALIA & REST OF
ASIA-PACIFIC
EUROPE
GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN, RUSSIA &
REST OF EUROPE
REST OF THE WORLD
GLOBAL BIOCHIP MARKET SHARE
- BY MICROARRAYS & APPLICATION - 2015-%
APPLICATION
MICROARRAYS